Figure 5.
Figure 5. VEGF promoter activity in K562 cells treated with imatinib mesylate (STI571). The different VEGF promoter constructs used in transient transfection assays are shown. The relative light units (RLU/μg protein) was measured 24 hours after transfection of 20 μg of the different reporter genes in the absence (-) or in the presence (+) of 5 μM imatinib is shown. The results are representative of 4 independent experiments performed in duplicate ± SE. The percentage of inhibition in the presence of imatinib is indicated.

VEGF promoter activity in K562 cells treated with imatinib mesylate (STI571). The different VEGF promoter constructs used in transient transfection assays are shown. The relative light units (RLU/μg protein) was measured 24 hours after transfection of 20 μg of the different reporter genes in the absence (-) or in the presence (+) of 5 μM imatinib is shown. The results are representative of 4 independent experiments performed in duplicate ± SE. The percentage of inhibition in the presence of imatinib is indicated.

Close Modal

or Create an Account

Close Modal
Close Modal